Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
NEW YORK (Reuters Health) – Postsurgical radioiodine treatment (RIT) has helped many children and adolescents living in Belarus who developed advanced radiation-induced differentiated thyroid carcinoma (DTC) after the…
NEW YORK (Reuters Health) – In women previously treated for Hodgkin lymphoma, mammography is as sensitive as breast MRI in detecting breast cancer – and the two modalities…
NEW YORK (Reuters Health) – Survival among women diagnosed with breast cancer when they are pregnant is comparable to that for nonpregnant women of reproductive age treated for…
NEW YORK (Reuters Health) – A meta-analysis of 25 studies has confirmed an increased risk of cancer among children born after fertility treatment. However, “Our results do not…
NEW YORK (Reuters Health) – A European study indicates that patients with T-cell prolymphocytic leukemia may respond well to induction chemotherapy using fludarabine, mitoxantrone and cyclophosphamide, followed by…
NEW YORK (Reuters Health) – Measuring urinary levels of prostate cancer antigen 3 (PSA3) may be more accurate than PSA testing in detecting prostate cancer, but evidence is…
The human papillomavirus (HPV) vaccine was designed to help prevent cervical cancer. For the vaccine to be effective it must be administered before sexual activity begins. A new study…
By David Douglas NEW YORK (Reuters Health) – Surgical resection of isolated pulmonary metastases can prolong overall survival in breast cancer patients, German researchers say. “On the basis…
By David Douglas NEW YORK (Reuters Health) – Adding lapatinib to paclitaxel provided significant benefits to women with newly diagnosed HER2-positive metastatic breast cancer in a recent study.…
NEW YORK (Reuters Health) – A European study indicates that patients with T-cell prolymphocytic leukemia may respond well to induction chemotherapy using fludarabine, mitoxantrone and cyclophosphamide, followed by…
